Abstract
Introduction
Neuropathic pain, commonly related to intervertebral disk (IVD) degeneration, responds poorly to standard pain treatments. Serotonin–noradrenaline reuptake inhibitors (SNRIs) have been reported to reduce neuropathic pain; however their effect on radiculopathy induced by lumbar disk herniation remains unclear. The aim of this study was to investigate the effect of SNRI duloxetine in rat model of IVD-related neuropathic pain.
Materials and methods
Effects of SNRI duloxetine were tested in Sprague–Dawley rats (n = 135). Neuropathic pain was induced by applying autologous nucleus pulposus (NP) on the left L5 dorsal root ganglion (DRG). Duloxetine in concentrations 0.4 mg/kg (low dose) and 1.2 mg/kg (high dose) or saline were administered orally for 10 days. Von Frey test was carried out on post-operative days 2, 7, 14, 21, and 28 to test pain sensitivity. Immunohistochemistry of L5 DRG and L5 segment of spinal cord (SC) was performed on days 7 and 21 to examine expressions of tumor necrosis factor alpha (TNF), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and ionized calcium-binding adapter molecule 1 (Iba1). On days 14, 21, and 28, expressions of TNF in DRG as well as NGF and BDNF in SC were tested by immunoblotting. Sham-operated rats and naive rats were used as controls.
Results
Duloxetine in both concentrations significantly improved pain threshold from postoperative day 21 onward, compared to the NP + saline group (p < 0.05). High-dose duloxetine significantly inhibited the expression of TNF in DRG (day 28, p < 0.05). Both duloxetine concentrations reduced the expression of NGF in SC (day 21, p < 0.05), but the expression of BDNF remained unchanged.
Conclusion
SNRI duloxetine inhibited neuropathic pain in rats possibly via down-regulating TNF, NGF, and microglia activation. We conclude that duloxetine, and most likely other SNRIs, may be used for the management of lumbar neuropathic pain.
Similar content being viewed by others
References
Aoki Y, Rydevik B, Kikuchi S et al (2002) Local applications of disc-related cytokines on spinal nerve roots. Spine 27:1614–1617
Aoki Y, Nakajima A, Ohtori S et al (2014) Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain? Arthritis Res Ther 16:R159
Beggs S, Trang T, Salter MW (2012) P2X4R + microglia drive neuropathic pain. Nat Neurosci 15:1068–1073
Bonnefont J, Chapuy E, Clottes E et al (2005) Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 114:482–490
Bouhassira D, Lanteri-Minet M, Attal N et al (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–387
Bowsher D (1997) The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline. A randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 13:327–331
Chizh BA, Illes P (2001) P2X receptors and nociception. Pharmacol Rev 53:553–568
Cho HJ, Kim SY, Park MJ et al (1997) Expression of mRNA for brain-derived neurotrophic factor in the dorsal root ganglion following peripheral inflammation. Brain Res 749:358–362
Gilron I, Watson CP, Cahill CM et al (2006) Neuropathic pain: a practical guide for the clinician. CMAJ 175:265–275
Goldstein DJ, Lu Y, Detke MJ et al (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109–118
Graff-Radford SB, Shaw LR, Nailboff BN (2000) Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 16:188–192
Gyoneva S, Traynelis SF (2013) Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors. J Biol Chem 288:15291–15302
Hashizume H, Kawakami M, Yoshida M et al (2007) Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats. Spine 32:315–320
Igarashi T, Kikuchi S, Shuvayev V et al (2000) Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine 25:2975–2980
Ito T, Ohtori S, Inoue G et al (2007) Glial phosphorylated p38 MAP kinase mediates pain in a rat model of lumbar disc herniation and induces motor dysfunction in a rat model of lumbar spinal canal stenosis. Spine 32:159–167
Kato K, Kikuchi S, Konno S et al (2008) Participation of 5-hydroxytryptamine in pain-related behavior induced by nucleus pulposus applied on the nerve root in rats. Spine 33:1330–1336
Kawakami M, Tamaki T, Weinstein JN et al (1996) Pathomechanism of pain-related behavior produced by allografts of intervertebral disc in the rat. Spine 21:2101–2107
Kayama S, Konno S, Olmarker K et al (1996) Incision of the anulus fibrosus induces nerve root morphologic, vascular, and functional changes. An experimental study. Spine 21:2539–2543
Kennedy C, Assis TS, Currie AJ et al (2003) Crossing the pain barrier: P2 receptors as targets for novel analgesics. J Physiol 553:683–694
Khakh BS, Burnstick G, Kennedy C et al (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107–118
Krabbe G, Matyash V, Pannasch U et al (2012) Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity. Brain Behav Immun 26:419–428
Krupkova O, Sekiguchi M, Klasen J et al (2014) Epigallocatechin 3-gallate suppresses interleukin-1β-induced inflammatory responses in intervertebral disc cells in vitro and reduces radiculopathic pain in rats. Eur Cell Mater 28:372–386
Loeser JD, Treede RD (2008) The Kyoto protocol of IASP basic pain terminology. Pain 137:473–477
Max MB, Schafer SC, Culnane M et al (1988) Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 38:1427–1432
Max MB, Lynch SA, Muir J et al (1992) Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250–1256
McCarron RF, Wimpee MW, Hudkins PG et al (1987) The inflammatory effect of nucleus pulposus. A possible element in the pathogenesis of low-back pain. Spine 12:760–764
Michael GJ, Averill S, Nitkunan A et al (1997) Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 17:8476–8490
Micó JA, Ardid D, Beffocoso E et al (2006) Antidepressants and pain. Trends Pharmacol Sci 27:348–354
Miyoshi S, Sekiguchi M, Konno S et al (2011) Increased expression of vascular endothelial growth factor protein in dorsal root ganglion exposed to nucleus pulposus on the nerve root in rats. Spine 36:E1–E6
Nagata K, Imai T, Yamada T et al (2009) Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. Mol Pain. doi:10.1186/1744-8069-5-20
Olmarker K, Rydevik B, Nordborg C (1993) Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equine nerve roots. Spine 18:1425–1432
Olmarker K, Brisby H, Yabuki S et al (1997) The effects of normal, frozen, and hyaluronidase-digested nucleus pulposus on nerve root structure and function. Spine 22:471–476
Olmarker K, Larsson K (1998) Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine 23:2538–2544
Onda A, Murata Y, Rydevik B et al (2003) Immunoreactivity of brain-derived neurotrophic factor in rat dorsal root ganglion and spinal cord dorsal horn following exposure to herniated nucleus pulposus. Neurosci Lett 352:49–52
Otoshi K, Kikuchi S, Konno S et al (2010) The reactions of glial cells and endoneurial macrophages in the dorsal root ganglion and their contribution to pain- related behavior after application of nucleus pulpose onto the nerve in rats. Spine 35:264–271
Otoshi K, Kikuchi S, Kato K et al (2011) Anti-HMGB1 neutralization antibody improves pain-related behavior induced by application of autologous nucleus pulposus onto nerve roots in rats. Spine 36:E692–E698
Peng B, Wu W, Li Z et al (2007) Chemical radiculitis. Pain 127:11–16
Raskin J, Pritchett YL, Wang F (2005) A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 6:346–356
Saarto T, Wiffen PJ (2010) Antidepressants for neuropathic pain: a Cochrane review. J Neurol Neurosurg Psychiarty 81:1372–1373
Saito H, Wakai J, Sekiguchi M et al (2014) The effect of selective serotonin reuptake inhibitor (SSRI) on pain-related behavior in a rat model of neuropathic pain. Eur Spine J 23:2401–2409
Sasaki N, Kikuchi S, Konno S et al (2007) Anti-TNF-alpha antibody reduces pain-behavior changes induced by epidural application of nucleus pulposus in a rat model depending on the timing of administration. Spine 32:413–416
Sekiguchi M, Otoshi K, Kikuchi S et al (2011) Analgesic effects of prostaglandin E2 receptor subtype EP1 receptor antagonist: experimental study of application of nucleus pulposus. Spine 36:1829–1834
Sindrup SH, Gram LF, Brosen K et al (1990) The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42:135–144
Smith EM, Pang H, Cirrincione C et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309:1359–1367
Tachihara H, Sekiguchi M, Kikuchi S et al (2008) Do corticosteroids produce additional benefit in nerve root infiltration for lumbar disc herniation? Spine 33:743–747
Takahashi K, Aoki Y, Ohtori S (2008) Resolving discogenic pain. Eur Spine J. doi:10.1007/s00586-008-0752-4
Tsuda M, Shigemoto-Mogami Y, Koizumi S et al (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424:778–783
Tsuda M, Inoue K, Salter MW (2005) Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci 28:101–107
Urani A, Chourbaji S, Gass P (2005) Mutant mouse models of depression: candidate genes and current mouse lines. Neurosci Biobehav Rev 29:805–828
Vollmar P, Haghikia A, Dermietzel R et al (2008) Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. Int J Neuropsychopharmacol 11(1):111–117
Wernicke JF, Pritchett YL, D’Souza DN et al (2006) A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67:1411–1420
Weurtz K, Quero L, Sekiguchi M, Klawitter M, Nerlich A, Konno S, Kikuchi S, Boos N (2011) The red wine polyphenol resveratrol shows promising potential for the treatment of nucleus pulposus-mediated pain in vitro and in vivo. Spine 36(21):E1373–E1384
Woolf CJ, Allchrone A, Safieh-Garabedian B et al (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 121:417–424
Yasuda H, Hotta N, Nakao K et al (2011) Superiority of duloxetine to placebo in improving diabetic neuropathic pain. Results of a randomized controlled trial in Japan. J Diabetes Investig 2:132–139
Yokogawa F, Kikuchi Y, Ishikawa Y et al (2002) An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg 95:163–168
Acknowledgments
The authors thank Akira Sato and Kazuo Sasaki for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is no potential conflict in this study.
Rights and permissions
About this article
Cite this article
Handa, J., Sekiguchi, M., Krupkova, O. et al. The effect of serotonin–noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats. Eur Spine J 25, 877–887 (2016). https://doi.org/10.1007/s00586-015-4239-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-015-4239-9